Desmoid Tumor clinical trials at UCLA

4 in progress, 1 open to eligible people

Showing trials for

  • Project: Every Child for Younger Patients With Cancer

    open to eligible people ages up to 25 years

    This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

    Los Angeles, California and other locations

  • New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery

    Sorry, in progress, not accepting new patients

    This phase II trial studies the side effects and how well nirogacestat works in treating patients less than 18 years of age with desmoid tumors that has grown after at least one form of treatment by mouth or in the vein that cannot be removed by surgery. Nirogacestat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

    Los Angeles, California and other locations

  • AL102 in Patients With Progressing Desmoid Tumors

    Sorry, in progress, not accepting new patients

    The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.

    Santa Monica, California and other locations

  • Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

    Sorry, in progress, not accepting new patients

    This study evaluates nirogacestat (PF-03084014) in the treatment of desmoid tumor/aggressive fibromatosis (DT/AF). In the double-blind phase, half of the participants will receive nirogacestat while the other half will receive placebo. Once participants are eligible to roll into the open-label phase, they will receive nirogacestat.

    Los Angeles, California and other locations

Our lead scientists for Desmoid Tumor research studies include .

Last updated: